AU2002234165A1 - Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents - Google Patents

Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents

Info

Publication number
AU2002234165A1
AU2002234165A1 AU2002234165A AU3416502A AU2002234165A1 AU 2002234165 A1 AU2002234165 A1 AU 2002234165A1 AU 2002234165 A AU2002234165 A AU 2002234165A AU 3416502 A AU3416502 A AU 3416502A AU 2002234165 A1 AU2002234165 A1 AU 2002234165A1
Authority
AU
Australia
Prior art keywords
pentafluorobenzenesulfonamides
combination therapy
antineoplastic agents
antineoplastic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002234165A
Inventor
Susan Schwendner
Pieter Timmermans
Jacqueline Walling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tularik Inc
Original Assignee
Tularik Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tularik Inc filed Critical Tularik Inc
Publication of AU2002234165A1 publication Critical patent/AU2002234165A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002234165A 2000-11-03 2001-11-02 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents Abandoned AU2002234165A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24587800P 2000-11-03 2000-11-03
US60/245,878 2000-11-03
PCT/US2001/051136 WO2002039958A2 (en) 2000-11-03 2001-11-02 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents

Publications (1)

Publication Number Publication Date
AU2002234165A1 true AU2002234165A1 (en) 2002-05-27

Family

ID=22928467

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002234165A Abandoned AU2002234165A1 (en) 2000-11-03 2001-11-02 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents

Country Status (3)

Country Link
US (1) US6822001B2 (en)
AU (1) AU2002234165A1 (en)
WO (1) WO2002039958A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69724777T2 (en) * 1996-02-22 2004-07-15 Tularik, Inc., South San Francisco PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
US6482860B1 (en) * 1996-07-19 2002-11-19 Tularik Inc. Pentafluorobenzenesulfonamides and analogs
UA59384C2 (en) * 1996-12-20 2003-09-15 Пфайзер, Інк. Preventing bone mass loss and recovery thereof by means of prostaglandin agonists
US20050250854A1 (en) * 2000-11-03 2005-11-10 Amgen Inc. Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
MXPA03008135A (en) 2001-03-14 2003-12-12 Bristol Myers Squibb Co Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
EP2405908B1 (en) 2009-03-11 2016-12-21 Ardea Biosciences, Inc. Pharmaceutical combination of rdea119/bay 869766 and gemcitabine for the treatment of specific cancers
CN103183724B (en) * 2010-05-27 2015-01-14 深圳信立泰药业股份有限公司 Preparation method of docetaxel conjugate
MX2020003695A (en) 2017-11-30 2020-08-03 Arrakis Therapeutics Inc Nucleic acid-binding photoprobes and uses thereof.

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1955207A (en) 1931-09-16 1934-04-17 Ig Farbenindustrie Ag Mothproofing agent
DE622494C (en) 1932-01-03 1935-11-29 I G Farbenindustrie Akt Ges Process for the preparation of mono- or polynitropolysulfones and their reduction products
US2358365A (en) 1940-08-03 1944-09-19 Parke Davis & Co Sulphonamide derivatives and process for obtaining the same
US2402623A (en) 1943-06-24 1946-06-25 Rohm & Haas Nu-nitroaryl haloarylsulphonamides
US2450863A (en) 1946-03-07 1948-10-05 Socony Vacuum Oil Co Inc Amides from sulfonyl fluorides
CH361275A (en) 1957-09-10 1962-04-15 Geigy Ag J R Process for the preparation of new arylsulfonarylamides
US2937202A (en) 1958-05-19 1960-05-17 Dow Chemical Co Substituted benzenesulfonanilides
GB938890A (en) 1961-02-03 1963-10-09 Boots Pure Drug Co Ltd New fungicidal compositions and compounds
NL301745A (en) 1962-12-17
CH504416A (en) 1966-12-05 1971-03-15 Ciba Geigy Ag Aromatic sulphamoyl cpd prepn.
US3505455A (en) 1966-12-15 1970-04-07 Ansul Co Nematocidal method
GB1242057A (en) 1968-07-04 1971-08-11 Ici Ltd Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators
NL174644C (en) 1970-04-13 1984-07-16 Minnesota Mining & Mfg METHOD FOR PREPARING A HERBICIDE COMPOUND; ALSO METHOD FOR PREPARING A PREPARATION WITH HERBICIDE ACTION.
US3951910A (en) 1973-12-28 1976-04-20 General Electric Company Flame retardant polycarbonate composition
US4013621A (en) 1975-04-29 1977-03-22 Ciba-Geigy Corporation Substituted sulfonamide derivatives of hindered phenols and stabilized compositions
DE2528697C2 (en) 1975-06-27 1986-02-20 Bayer Ag, 5090 Leverkusen Process for the production of salicylaldehydes
US4034110A (en) 1976-09-20 1977-07-05 Hoffmann-La Roche Inc. Anthelmintics effective against liver flukes
DE2809377A1 (en) 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh PHENOXYALKYL CARBONIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4239699A (en) 1978-05-24 1980-12-16 Henkel Corporation Sulfonamidophenols, metal complexes thereof, and solutions containing such compounds for use in extraction of metal values
FR2456731A1 (en) 1979-05-16 1980-12-12 Choay Sa Guanidino and amino benzoate(s) and phenyl sulphonate(s) - and related cpds. inhibit protease(s) and have bacteriostatic and fungistatic activity
DE3000377A1 (en) 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim NEW SULPHONAMIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
US4373017A (en) 1980-03-05 1983-02-08 Konishiroku Photo Industry Co., Ltd. Photosensitive compound and photosensitive material containing it
US4483986A (en) 1982-05-03 1984-11-20 Eli Lilly And Company 4-Nitrobenzophenone compounds
DE3587500T2 (en) * 1984-12-04 1993-12-16 Lilly Co Eli Tumor treatment in mammals.
NZ215272A (en) 1985-02-27 1989-08-29 Mitsui Toatsu Chemicals Fungicidal n-(2-chloro-4-nitrophenyl)-benzenesulphonamide derivatives and compositions thereof
US4692466A (en) 1985-02-28 1987-09-08 Mitsui Toatsu Chemicals, Incorporated N-(2-chloro-4-trifluoromethylphenyl)-3-trifluoromethylbenzenesulfonamide derivative and agricultural fungicide containing same
DE3535167A1 (en) 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh NEW SULFONYL-PHENYL (ALKYL) AMINES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS
DE3623184A1 (en) 1986-07-10 1988-01-14 Kali Chemie Ag METHOD FOR PRODUCING N-FLUORSULFONAMIDES
US4883914A (en) 1987-08-17 1989-11-28 American Cyanamid Company Benzenesulfonyl carboxamide compounds useful as herbicidal agents
DE3804990A1 (en) 1988-02-18 1989-08-31 Basf Ag HERBICIDALLY EFFECTIVE, HETEROCYCLICALLY SUBSTITUTED SULFONAMIDES
DE3821540A1 (en) 1988-06-25 1989-12-28 Boehringer Mannheim Gmbh NEW SULFONAMIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAL PRODUCTS CONTAINING SULFONAMIDES
US5280043A (en) 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
DE3905075A1 (en) 1989-02-18 1990-08-30 Hoechst Ag BENZOLSULPHONAMIDES AND METHOD FOR THE PRODUCTION THEREOF
FR2645537B1 (en) 1989-04-05 1994-03-04 Fabre Medicament Pierre NOVEL SULFONAMIDES DERIVED FROM BENZOCYCLIC OR BENZOHETEROCYCLIC ACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2665440B1 (en) 1990-07-31 1994-02-04 Lipha NOVEL SUBSTITUTED CYCLOALKYLSULFONAMIDES, METHODS OF PREPARATION AND MEDICAMENTS CONTAINING THEM.
US5189211A (en) 1990-08-01 1993-02-23 Taisho Pharmaceutical Co., Ltd. Sulfonamide derivatives
EP0472053B1 (en) 1990-08-20 1998-06-17 Eisai Co., Ltd. Sulfonamide derivatives
US5780483A (en) 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
AU6112896A (en) 1995-06-07 1996-12-30 Sugen, Inc. Tyrphostin-like compounds for the treatment of cell prolifer ative disorders or cell differentiation disorders
DE69724777T2 (en) 1996-02-22 2004-07-15 Tularik, Inc., South San Francisco PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
US6482860B1 (en) 1996-07-19 2002-11-19 Tularik Inc. Pentafluorobenzenesulfonamides and analogs
ATE399547T1 (en) 1996-10-15 2008-07-15 Searle Llc USE OF CYCLOOXYGENASE-2 INHIBITORS TO TREAT AND PREVENT NEOPLASIA
BR9713522A (en) 1996-11-19 2000-03-21 Searle & Co Method of using cyclooxygenase-2 inhibitors as antiangiogenic agents.
US5773236A (en) 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
US6284923B1 (en) 1997-08-22 2001-09-04 Tularik Inc Substituted benzene compounds as antiproliferative and cholesterol lowering action
ATE245641T1 (en) * 1998-02-17 2003-08-15 Tularik Inc ANTIVIRAL PYRIMIDINE DERIVATIVES
DE69911017T2 (en) * 1998-06-25 2004-07-08 Tularik, Inc., South San Francisco ARYLSULFONANILID-PHOSPHATE
US6153585A (en) * 1998-07-20 2000-11-28 Tularik Inc. Arylsulfonanilide derivatives
KR100642184B1 (en) 1998-09-23 2006-11-10 암젠 인크 Arylsulfonanilide Ureas
AU2190700A (en) 1998-12-17 2000-07-03 Tularik Inc. Tubulin-binding agents
ES2273688T3 (en) 1999-04-14 2007-05-16 Dana-Farber Cancer Institute, Inc. PROCEDURE AND COMPOSITION FOR CANCER TREATMENT.
CO5170498A1 (en) 1999-05-28 2002-06-27 Abbott Lab BIARIL SULFONAMIDS ARE USEFUL AS CELL PROLIFERATION INHIBITORS
ES2241639T3 (en) 1999-07-29 2005-11-01 Amgen, Inc. COMBINATION THERAPY USING A PENTAFLUOROBENCENSULFONAMIDS AND PLATINUM COMPOUND.
US6465448B1 (en) * 1999-08-13 2002-10-15 Case Western Reserve University Methoxyamine potentiation of temozolomide anti-cancer activity

Also Published As

Publication number Publication date
WO2002039958A9 (en) 2003-05-22
WO2002039958A3 (en) 2002-09-06
US6822001B2 (en) 2004-11-23
WO2002039958A2 (en) 2002-05-23
US20020177548A1 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
GB0028429D0 (en) Therapy
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2001233296A1 (en) Establishing and maintaining therapeutic hypothermia
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001243515A1 (en) Combination drug therapy
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2451500A (en) Therapeutic agents
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2002234165A1 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU2001270129A1 (en) Human phosphodiesterases
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
AU2001273903A1 (en) Therapeutic agents
AU4432001A (en) Trityl-type compounds and their use
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
AU2001268653A1 (en) Combination hiv therapy including camptothecin
AU5973600A (en) Therapeutic agents
AU2001275696A1 (en) Therapeutic agent
AU2001291962A1 (en) Angiogenic agents and their uses
GB0018887D0 (en) Compound and their therapeutic use
AU2669201A (en) Taccalonolides and their use
WO2001085090A8 (en) Therapy device
AU6150200A (en) Therapeutic agents